![Many Minds. One Focus – The Brain Cancer Centre](https://oncodaily.com/pub/uploads/2024/09/1725263674314-1280x853.jpeg)
Many Minds. One Focus – The Brain Cancer Centre
The Brain Cancer Centre made the following post on LinkedIn:
“Awesome to see our Research Rockstar Prof Misty Jenkins PhD AO work in the Herald Sun today.
Misty and her WEHI (Walter and Eliza Hall Institute of Medical Research) teammates Leesa Lertsumitkul Melinda Iliopoulos, Stacie Wang, Alexander Davenport, Ryan Cross authored this study, proudly funded by The Brain Cancer Centre with funding partners including the National Health and Medical Research Council (NHMRC), Robert Connor Dawes (RCD) Foundation, Isabella & Marcus Foundation, Medical Research Future Fund (MRFF), Cure Brain Cancer Foundation and Zoe’s Fight Foundation Inc.
Their cutting edge new immunotherapy not only targets and destroys an aggressive form of brain cancer, but also helps the immune system develop a lasting defence against it.
The specific immunotherapy known as CAR T cell therapy could revolutionise treatment for gliomas, an incurable brain cancer.
‘CAR T cell therapy is clever because it uses a patient’s own immune cells and engineers them to recognise and kill the tumour, with no long-term side effects,’ Misty said.
‘The potential to revolutionise brain cancer treatment – like what has been achieved for other cancers – makes this a truly exciting time,’ she said.
The discoveries provide fresh hope for patients, not just for a cure, but for more precious time. We’re excited to see where this incredible research will lead.
We’re proud to support brilliant minds like Prof Misty Jenkins & her team.
Many Minds. One Focus.”
Source: The Brain Cancer Centre/LinkedIn
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023